SEC Tracker
Get the app

Possible new Lantern Pharma shares

LTRNDilution

Known so far: no new shares from the prospectus covers read · shelf room about $11.3M · not yet read: warrants, converts, options, ATM.

Shelf room

  • Room today about $11.3M, maybe lower
  • One third of float $11.3M ($33.9M float, Jun 30, 2025)
  • Sold off it, 12 months nothing
How this is worked out

Shelf room about $11.3M on the S-3 of May 24, 2024: the baby-shelf rule (public float under $75M) caps sales at one third of the $33.9M public float stated as of Jun 30, 2025, $11.3M, nothing sold off it in the last 12 months; 3 more sales off the shelf with no size read, so the room may be lower. Sources: S-3 May 24, 2024, effective Jun 10, 2024 · public float, as of Jun 30, 2025 · 424B5 Mar 30, 2026 · 424B5 May 14, 2026 · 424B5 Sep 30, 2026.

What could become new Lantern Pharma (LTRN) shares, from its 10-Q, 10-K, S-1 or 424B filings.

Read so far: the cover share count (12.8M shares, +18% from 10.8M on Aug 8, 2025). Not read yet: warrants, convertible notes, options and RSUs and an ATM program. Read them on EDGAR: the latest 10-Q · S-1 registration filings.

Shares outstanding

12.8M

Nov 2024 to Aug 2026: from 10.8M to 12.8M.

From the share count on the cover of each 10-Q and 10-K, dated as each cover states.